BIOCAUSE HEILEN PHARMA: Ibuprofen suspension has obtained the drug registration certificate
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, BIOCAUSE HEILEN PHARMA announced that the company recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration ("NMPA"), involving the product: "Ibuprofen Suspension". The announcement stated that the registration classification of the ibuprofen suspension is Category 4 chemical drugs, which were reviewed and approved according to the technical requirements consistent with the quality and efficacy of the reference preparation, and after approval, it is deemed to have passed the consistency evaluation of the quality and efficacy of generic drugs
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments